Ni, H.; Kumbrink, J.; Mayr, D.; Seiler, A.; Hagemann, F.; Degenhardt, T.; Sagebiel, S.; Würstlein, R.; Kates, R.; Harbeck, N.;
et al. Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer. J. Pers. Med. 2021, 11, 835.
https://doi.org/10.3390/jpm11090835
AMA Style
Ni H, Kumbrink J, Mayr D, Seiler A, Hagemann F, Degenhardt T, Sagebiel S, Würstlein R, Kates R, Harbeck N,
et al. Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer. Journal of Personalized Medicine. 2021; 11(9):835.
https://doi.org/10.3390/jpm11090835
Chicago/Turabian Style
Ni, Hua, Jörg Kumbrink, Doris Mayr, Alina Seiler, Friederike Hagemann, Tom Degenhardt, Sabine Sagebiel, Rachel Würstlein, Ronald Kates, Nadia Harbeck,
and et al. 2021. "Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer" Journal of Personalized Medicine 11, no. 9: 835.
https://doi.org/10.3390/jpm11090835
APA Style
Ni, H., Kumbrink, J., Mayr, D., Seiler, A., Hagemann, F., Degenhardt, T., Sagebiel, S., Würstlein, R., Kates, R., Harbeck, N., & Eggersmann, T. K.
(2021). Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer. Journal of Personalized Medicine, 11(9), 835.
https://doi.org/10.3390/jpm11090835